Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features.

Related Articles:

• Levodopa/carbidopa intestinal gel infusion can improve camptocormia in Parkinson's disease. June 22, 2019 Related ArticlesLevodopa/carbidopa intestinal gel infusion can improve camptocormia in Parkinson's disease. Parkinsonism Relat Disord. 2019 Jun 10;: Authors: Morales-Briceño H, Mahant N, Duma S, Martin A, Griffith J, Tsui D, Fung VS PMID: 31221564 [PubMed - as supplied by publisher]
• Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson's Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation. September 27, 2019 Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson's Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation. J Mov Disord. 2019 Sep;12(3):192-194 Authors: Kimber TE, Zhuang Y, Thompson PD PMID: 31556262 [PubMed]
• Levodopa-carbidopa intestinal gel therapy after deep brain stimulation. November 7, 2017 Levodopa-carbidopa intestinal gel therapy after deep brain stimulation. Mov Disord. 2017 Nov 06;: Authors: Kumar N, Murgai A, Naranian T, Jog M, Fasano A PMID: 29105810 [PubMed - as supplied by publisher]
• Necessity of long-term alertness in levodopa-carbidopa intestinal gel infusion for PD patients. October 20, 2018 Related ArticlesNecessity of long-term alertness in levodopa-carbidopa intestinal gel infusion for PD patients. Mov Disord. 2017 02;32(2):300-301 Authors: Klostermann F, Bojarski C, Marzinzik F, Maier A, Schindlbeck KA, Ehlen F PMID: 27859611 [PubMed - indexed for MEDLINE]
• Enteral feeding in Parkinson's patients receiving levodopa/carbidopa intestinal gel. July 6, 2017 Enteral feeding in Parkinson's patients receiving levodopa/carbidopa intestinal gel. Parkinsonism Relat Disord. 2017 Jun 27;: Authors: Bove F, Bentivoglio AR, Naranian T, Fasano A PMID: 28676196 [PubMed - as supplied by publisher]
• Long-Term Successful Treatment of CIDP-like Polyneuropathy Induced by Levodopa-Carbidopa Intestinal Gel with Intravenous Immunoglobulin. July 23, 2019 Long-Term Successful Treatment of CIDP-like Polyneuropathy Induced by Levodopa-Carbidopa Intestinal Gel with Intravenous Immunoglobulin. Eur J Neurol. 2019 Jul 22;: Authors: Pintér D, Deli G, Juhász A, Pál E, Janszky J, Kovács N Abstract Polyneuropathy (PNP) can develop in approximately 4.1% of patients treated with levodopa-carbidopa intestinal gel (LCIG)[1]. Almost all of these patients suffer from mild, chronic, progressive, axonal,…
• Long-term safety and efficacy of 24-hour levodopa-carbidopa intestinal gel in Parkinson's disease. October 12, 2019 Long-term safety and efficacy of 24-hour levodopa-carbidopa intestinal gel in Parkinson's disease. Mov Disord. 2019 Oct 11;: Authors: Morales-Briceño H, Mahant N, Ha AD, Chang FCF, Kim SD, Griffith J, Tsui D, Galea D, Fung VSC PMID: 31603586 [PubMed - as supplied by publisher]
• Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review". August 20, 2016 Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review". CNS Drugs. 2016 Aug 19; Authors: Lambarth AT PMID: 27541607 [PubMed - as supplied by publisher]
• Old Drugs, New Delivery Systems in Parkinson's Disease. June 5, 2019 Related ArticlesOld Drugs, New Delivery Systems in Parkinson's Disease. Drugs Aging. 2019 Jun 03;: Authors: Gupta HV, Lyons KE, Pahwa R Abstract Levodopa is the mainstay of treatment in Parkinson's disease (PD). As the disease progresses, variations in plasma levodopa levels lead to motor fluctuations. The common reasons behind variations in the plasma levels include delayed gastric emptying, small intestinal…
• Acute cholecystitis induced by surgery for levodopa-carbidopa intestinal gel therapy: Possible relationship to pre-existing gallstones. April 18, 2018 Related ArticlesAcute cholecystitis induced by surgery for levodopa-carbidopa intestinal gel therapy: Possible relationship to pre-existing gallstones. Parkinsonism Relat Disord. 2018 Apr 03;: Authors: Nose K, Fujioka S, Umemoto G, Yamashita K, Shiwaku H, Hayashi Y, Mishima T, Fukae J, Hasegawa S, Tsuboi Y PMID: 29661695 [PubMed - as supplied by publisher]
• Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review". August 20, 2016 Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review". CNS Drugs. 2016 Aug 19; Authors: Wirdefeldt K, Odin P, Nyholm D PMID: 27541606 [PubMed - as supplied by publisher]
• Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States. July 7, 2019 Related ArticlesCurrent Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States. Adv Ther. 2019 Jul 05;: Authors: Amjad F, Bhatti D, Davis TL, Oguh O, Pahwa R, Kukreja P, Zamudio J, Metman LV Abstract In 2015, the US Food and Drug Administration approved levodopa-carbidopa intestinal gel (LCIG; also known as carbidopa-levodopa…
• Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors. October 16, 2019 Related ArticlesBeyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors. Parkinsonism Relat Disord. 2019 Oct 09;: Authors: Artusi CA, Balestrino R, Imbalzano G, Bortolani S, Montanaro E, Tuttobene S, Fabbri M, Zibetti M, Lopiano L Abstract INTRODUCTION: Although levodopa/carbidopa intestinal infusion (LCIG) proved a sustained efficacy on Parkinson's disease (PD) motor fluctuations, there is a…
• Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation. June 22, 2019 Related ArticlesDynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation. J Neural Transm (Vienna). 2019 Jun 20;: Authors: Richter D, Bartig D, Jost W, Jörges C, Stumpe B, Gold R, Krogias C, Tönges L Abstract Parkinson's disease (PD) is a very common extrapyramidal movement…
• Levodopa-carbidopa intestinal gel therapy after deep brain stimulation. May 17, 2019 Related ArticlesLevodopa-carbidopa intestinal gel therapy after deep brain stimulation. Mov Disord. 2018 02;33(2):334-335 Authors: Kumar N, Murgai A, Naranian T, Jog M, Fasano A PMID: 29105810 [PubMed - indexed for MEDLINE]
• Directional local field potential recordings for symptom-specific optimization of deep brain stimulation. June 21, 2018 Related ArticlesDirectional local field potential recordings for symptom-specific optimization of deep brain stimulation. Mov Disord. 2017 04;32(4):626-628 Authors: Fernández-García C, Foffani G, Dileone M, Catalán-Alonso MJ, González-Hidalgo M, Barcía JA, Alonso-Frech F PMID: 28339118 [PubMed - indexed for MEDLINE]
• [Complications and troubleshooting at the initial introduction of Levodopa-carbidopa continuous infusion gel therapy: A single-center study]. April 2, 2019 Related Articles[Complications and troubleshooting at the initial introduction of Levodopa-carbidopa continuous infusion gel therapy: A single-center study]. Rinsho Shinkeigaku. 2019 Mar 30;: Authors: Mukai Y, Nishikawa N, Takahashi Y, Murata M Abstract Levodopa-carbidopa intestinal gel (LCIG) therapy has been established as a device-aided treatment for advanced Parkinson's disease. We retrospectively investigated the issues related to LCIG therapy in patients with…
• Comparison Between Levodopa-Carbidopa Intestinal Gel Infusion and Subthalamic Nucleus Deep-Brain Stimulation for Advanced Parkinson's Disease: A Systematic Review and Meta-Analysis. September 12, 2019 Comparison Between Levodopa-Carbidopa Intestinal Gel Infusion and Subthalamic Nucleus Deep-Brain Stimulation for Advanced Parkinson's Disease: A Systematic Review and Meta-Analysis. Front Neurol. 2019;10:934 Authors: Liu XD, Bao Y, Liu GJ Abstract Background: Currently, some advanced treatments such as Levodopa-Carbidopa intestinal gel infusion (LCIG), deep-brain stimulation (DBS), and subcutaneous apomorphine infusion have become alternative strategies for advanced Parkinson's disease (PD). However,…
• Jejunal catheter placement for levodopa-carbidopa infusion in a patient with Billroth I gastrectomy. August 31, 2017 Related ArticlesJejunal catheter placement for levodopa-carbidopa infusion in a patient with Billroth I gastrectomy. Endoscopy. 2016;48 Suppl 1:E288 Authors: Markos P, Bilic B, Miletic V, Rustemovic N PMID: 27626213 [PubMed - indexed for MEDLINE]
• Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease. September 25, 2019 Related ArticlesLevodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease. Drugs. 2019 Sep 23;: Authors: Hoy SM Abstract An enteral suspension (ES)/intestinal gel formulation of levodopa/carbidopa (hereafter referred to as levodopa/carbidopa ES) [Duodopa® (EU); Duopa™ (USA)] has been developed to overcome the fluctuating plasma levodopa concentrations associated with oral levodopa/carbidopa formulations. In various countries, including those of the EU (under…